TY - JOUR
T1 - Exon-skipping therapy for Duchenne muscular dystrophy - Authors' reply
AU - Arechavala-Gomeza, Virginia
AU - Cirak, Sebahattin
AU - Anthony, Karen
AU - Morgan, Jennifer
AU - Muntoni, Francesco
PY - 2012/1/14
Y1 - 2012/1/14
N2 - A general catalytic procedure for the cycloaddition of diazo amides to fullerene C60 in the presence of the three-component catalyst, Pd(acac)2–PPh3–Et3Al, has been developed. Depending on the reaction conditions, pyrazolinofullerenes or methanofullerenes are formed.
AB - A general catalytic procedure for the cycloaddition of diazo amides to fullerene C60 in the presence of the three-component catalyst, Pd(acac)2–PPh3–Et3Al, has been developed. Depending on the reaction conditions, pyrazolinofullerenes or methanofullerenes are formed.
UR - http://www.mendeley.com/research/exonskipping-therapy-duchenne-muscular-dystrophy-authors-reply
U2 - 10.1016/S0140-6736(12)60064-6
DO - 10.1016/S0140-6736(12)60064-6
M3 - Letter
SN - 1474-547X
JO - The Lancet
JF - The Lancet
ER -